ARNA Panacea ICO details
Start Date: 2017-12-15
End date: 2018-2-10
ARNA Genomics is an innovative biotechnological company, launched on the basis of the scientific and research laboratory and a team of like-minded people, engaged in development and research of early detection methods of oncological diseases with the purpose of launch of diagnostic tests for early cancer detection on the global market.
Our mission is to increase the life expectancy and significantly reduce human mortality by means of global market launch of most recent, unique in efficiency methods of screening (screening study with the purpose of detection and prevention of disease development in population), diagnostics (correct diagnosing) and monitoring of treatment process of oncological diseases.
ARNA Genomics company has discovered a technology which allows to develop tests for different types (nosologies) of cancer. Besides, the company has also developed a unique concept of blockchain based ecosystem, which will be used as an instrument to support R&D and implementation of biotechnologies worldwide.
We have completed R&D for the first product based on our technology – breast cancer test.
Colon cancer test is currently in R&D stage. Besides, we are currently developing a blockchain platform solution – ARNA Panacea, which will soon allow to change the world by making launch of new biotech solutions against cancer much easier and faster.
About ARNA Genomics
We are ARNA Genomics. We are an innovative biotechnological company, launched by a team of likeminded scientists and businessmen and grown from the scientific and research laboratory into full scale venture. We develop revolutionary early detection methods for select cancers in order to launch a line of diagnostic tests for early cancer detection on the global markets.
Our mission: to increase the life expectancy and significantly reduce human mortality. We relentlessly pursue this goal through cutting edge screening methods, diagnosis correction, treatment monitoring, and increasing patient adherence.
Our Innovation: ARNA Genomics has discovered a technology enabling highly specific tests development for different cancers. Besides, the company has also developed a unique concept of blockchain-based ecosystem-grade platform intended for use as an instrument to support R&D and implementation of biotechnologies worldwide.
Our Pledge: ARNA Genomics have completed R&D for its first product – ARNA Breast Cancer test.
The test for colon cancer test is currently in an advanced R&D stage. We devote all our resources to complete development of ARNA Panacea – a blockchain platform, that will hope will change the world by making launch of new biotech and treatment solutions against cancers much easier, cheaper and faster.
ARNA Panacea blockchain expert system
Key pain of modern healthcare is lack of trust between patients and healthcare system (Example – Homeopacy) Patients accuse healthcare major in selection bias that sabotages efficient inexpensive treatments ARNA Panacea blockchain will create expert system validating medical procedure results by the medical followup coming later All data will be fraud-proof, anonimous, transparent, and distributed Initially ARNA PANACEA will serve for validation of novel medical technologies later it will become the marketplace of healthcare attracting all players.
Blockchain can make analogues of real time processes, which allows:
- to accelerate and to reduce the price of all processes;
- to redistribute rewards for every participant of the process, based on the present market mechanisms, which creates a correct incentive system;
- to make available and transparent as much as possible communication of all participants of the process from creation of biotechnological solution and its examination to commercialization, acceleration of market entry and availability to end consumers.
Set of these factors will impact the survival rate and human life expectancy.
Our solution of this problem is creation of an integrated ecosystem based on blockchain for conduction of all the stages, accompanying biotechnological products – from development to statistics and data collection – ARNA Panacea.
ARNA Panacea Platform
The system is expected to unite and serve the entire marketplace of global healthcare by providing multiple benefits to all stakeholders:
- patients will be excited by the ability to observe and validate the constantly growing set of facts on the efficacy of diverse treatments
- doctors will start using ARNA Panacea first as the storage of patient data and later as the tool to validate their own therapeutic successes
- insurance companies will follow patients and doctors to employ ARNA Panacea in patient management
- pharmaceutical companies will come to receive encrypted information about the modern state of the diseases and to recruit freshly diagnosed patients for all kind of research without revealing patient identity
- regulators will come to use ARNA Panacea data to establish safety and efficacy of healthcare technologies
- nvestors and scientists will join the community to exchange inventions and financing